Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y, Li Y, Wedrén S, Li G, Charn TH, Desai KV, Bonnard C, Czene K, Humphreys K, Darabi H, Einarsdóttir K, Heikkinen T, Aittomäki K, Blomqvist C, Chia KS, Nevanlinna H, Hall P, Liu ET, Liu J.
Li Y, et al. Among authors: einarsdottir k.
Breast Cancer Res. 2011 Jan 26;13(1):R10. doi: 10.1186/bcr2817.
Breast Cancer Res. 2011.
PMID: 21269472
Free PMC article.